🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some experts said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Response and Material Elimination

According to the social media company, the platform has removed problematic material and prohibited associated hashtags and query recommendations. The company said it was committed to maintaining the platform safe and investing in enhancing compliance measures.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of joining one community, a vendor posted contact information, where most transactions occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, messages display dark colored packages with postal service stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her staff has already seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly significant health risks”.